Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Host factors involved in myxovirus replication" refers to a broad category of cellular proteins and pathways that are hijacked by viruses in the Orthomyxoviridae (e.g., Influenza) and Paramyxoviridae (e.g., Measles, Mumps) families to facilitate their life cycle. These factors include cell surface receptors for entry (such as sialic acid), intracellular transport proteins (like importins), and nuclear machinery required for viral RNA synthesis and processing. While individual proteins within this group, such as Exportin-1 (XPO1) or Myxovirus resistance protein 1 (MX1), are specific therapeutic targets, the collective term itself describes a functional class rather than a single molecular entity. In drug discovery, targeting host factors is an attractive strategy to develop antivirals with a high barrier to resistance, as the virus cannot easily mutate to bypass a required cellular component. However, because these factors often perform essential physiological roles for the host, identifying a therapeutic window that inhibits viral replication without causing significant host toxicity remains a major challenge.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host factors involved in myxovirus replication.